Brief: Eve Investments Says Omni Innovation Enters Agreement With Myopharm Ltd
13/01/2021 21:31
Jan 14 (Reuters) - Eve Investments Ltd EVE.AX :
* OMNI INNOVATION ENTERS AGREEMENT WITH MYOPHARM LTD FOR
RIGHTS TO
OMNI INNOVATION'S PRE-MEAL GLYCAEMIC CONTROL PRODUCT
Source text for Eikon: ID:nASX6HFX0h
Further company coverage: EVE.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eve Health
See all newsBrief: Eve Health Appoints Ben Rohr As Chief Executive Officer
Australia's EVE Health slips on discounted placement
Brief: Eve Health Group Seeks Trading Halt For Capital Raising Consideration And Planning
Brief: Eve Health Signs Telehealth Services Agreement With Hubmed
Brief: Eve Health Group Raises A$1.1 MLN At A$0.030 Per Share